Clinical Trial Update: CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

View source ↗

Summary

The report provides long-term antibody response data from a cytomegalovirus glycoprotein B vaccine trial conducted by University College London. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV glycoprotein B vaccine (glycoprotein B vaccine)

Snippet

Sponsor: University College, London | Conditions: Viraemia | Status: COMPLETED